ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Process Industries

Sekisui Chemical Co., Ltd.

Business Summary

Sekisui Chemical Co., Ltd. engages in the manufacture of high-performance plastics for medical, automotive, and information technology industries; and residential housing construction. It operates through the following segments: Housing, Environment and Lifeline, High Performance Plastics, Medical, and Others. The Housing segment handles the construction, sale, and renovation of housing units. It also provides real estate and housing services. The Environment and Lifeline segment offers PVC pipes and fittings, pipe rehabilitation materials, reinforced plastic composite pipes, and synthetic wood. The High-Performance Plastics segment sells interlayer films for laminated glass, foamed polyolefin, tapes, fine particles for liquid crystals, photosensitive materials, and functional resins for infrastructure materials. The Medical segment covers clinical diagnostic reagents, clinical testing equipment, active pharmaceutical ingredients and intermediates. The Others segment covers film-type lithium-ion batteries. The company was founded on March 3, 1947 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2022 JPYUSD
Gross Profit341,831M3,041.94M
Operating income88,880M790.93M
Income before tax69,859M621.67M
Net income37,068M329.86M
Diluted EPS83.160.74
Dividends Per Share490.43
Total Assets1,198.92B9,877.82M
Total liabilities496,165M4,087.86M
Total equity674,637M5,558.28M
Operating cash flow105,023M934.59M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 1,107.42B 1,142.71B 1,129.25B 1,056.56B 1,157.94B
Gross Profit 351,131M 355,585M 348,773M 315,713M 341,831M
Operating income 99,233M 95,688M 87,976M 67,302M 88,880M
Income before tax 94,342M 93,908M 83,787M 63,179M 69,859M
Net income 63,460M 66,094M 59,181M 41,544M 37,068M
EBITDA 137,665M 137,325M 133,232M 116,647M 137,584M
Diluted EPS 133.57 141.64 128.79 91.91 83.16
Dividends Per Share 40 44 46 47 49
Total Assets 994,137M 1,023.70B 1,105.78B 1,150.14B 1,198.92B
Total liabilities 381,657M 390,956M 471,559M 455,747M 496,165M
Total equity 588,037M 607,281M 609,318M 667,067M 674,637M
Operating cash flow 82,272M 85,213M 92,647M 75,271M 105,023M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 9,991.92M 10,304.49M 10,386.25M 9,962.15M 10,304.50M
Gross Profit 3,168.12M 3,206.51M 3,207.82M 2,976.81M 3,041.94M
Operating income 895.34M 862.87M 809.15M 634.58M 790.93M
Income before tax 851.21M 846.82M 770.62M 595.70M 621.67M
Net income 572.57M 596.00M 544.31M 391.71M 329.86M
EBITDA 1,242.10M 1,238.33M 1,225.39M 1,099.84M 1,224.35M
Diluted EPS 1.20 1.27 1.18 0.86 0.74
Dividends Per Share 0.36 0.39 0.42 0.44 0.43
Total Assets 9,347.78M 9,248.82M 10,242.98M 10,408.53M 9,877.82M
Total liabilities 3,588.68M 3,532.15M 4,368.10M 4,124.40M 4,087.86M
Total equity 5,529.26M 5,486.57M 5,644.18M 6,036.80M 5,558.28M
Operating cash flow 742.30M 768.41M 852.11M 709.71M 934.59M

Valuation Measures

Mar 2022
Operating margin7.67%
Profit margin3.20%

Key executives

  • President & Representative Director: Keita Kato
  • Executive Officer, Manager-R&D Center: Katsunori Mukai
  • Director, Executive Officer & Personnel Manager: Kazuya Murakami
  • Executive Officer & Manager-Legal Affairs: Naoko Fukutomi
  • Manager-Business Administration: Tatsuya Nishida


  • Sekisui Chemical Co., Ltd. (5.5%)
  • Mondrian Investment Partners Ltd. (5.0%)
  • Dai-ichi Life Holdings, Inc. (4.0%)
  • Asahi Kasei Corp. (3.2%)
  • Nomura Asset Management Co., Ltd. (3.0%)
  • Impax Asset Management Ltd. (2.8%)
  • Sekisui Chemical Group Employee Stock Owmership Plan (2.2%)
  • Schroder Investment Management Ltd. (1.9%)
  • The Vanguard Group, Inc. (1.9%)
  • Baillie Gifford & Co. (1.7%)

Contact Details

  • Website:
  • Address: Dojima Kanden Building, 2-4-4 Nishitemma, Osaka, 530-8565, Japan
  • Phone: +81.6.6365.4110

Related Companies

  • Sekisui Polymatech Europe BV
  • Sekisui Xenotech, Llc
  • Sekisui Town Management KK
  • Sekisui Medical Technology (Suzhou) Co., Ltd.
  • Yamanashi Sekisui KK
  • Hanyu Sekisui KK
  • Sekisui Alveo KK
  • SoflanWiz Co., Ltd.
  • Sekisui Chemical Board Incentive Plan
  • Sekisui Chemical Employee Incentive Plan
  • Sekisui Specialty Chemicals (Thailand) Co. Ltd.
  • Sekisui Aerospace
  • SEKISUI Polymer Innovations LLC
  • Sekisui (Shanghai) Environmental Technology Co. Ltd.
  • Sekisui Alveo SRL
  • Sekisui-Alveo SA
  • Sekisui High Performance Packaging (Langfang) Co. Ltd.
  • SEKISUI ALVEO (Benelux) BV
  • Sekisui (Hong Kong) Ltd.
  • Sekisui Chemical Singapore (Pte) Ltd.
  • Sekisui S-LEC (Thailand) Co. Ltd.
  • PT Sekisui Indonesia
  • Sekisui S-Lec (Suzhou) Co. Ltd.
  • Sekisui Refresh Co. Ltd.
  • Sekisui Alveo Representative Ltda.
  • Sekisui Diagnostics P.E.I., Inc.
  • PT Adyawinsa Sekisui Techno Molding
  • Sekisui-SCG Industry Co. Ltd.
  • Sekisui Chemical Thailand Co. Ltd.
  • Sekisui SPR Americas LLC


  • NDFOS Co., Ltd.
  • Eastman Chemical Company
  • Georg Fischer AG
  • Tredegar Corporation
Last Updated on 30 Sep, 2022

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more